Tiffany Kershaw

Tiffany Kershaw is a seasoned professional in clinical quality assurance and regulatory inspection management, currently serving as Director of Clinical Quality Assurance at Apogee Therapeutics since May 2025. With a significant tenure at Bristol Myers Squibb from July 2020 to December 2024, Tiffany directed efforts for regulatory health authority inspection readiness, achieving a noteworthy record of no FDA Form 483s. Previous roles include Director at Karuna Therapeutics and Associate Director at Moderna, focusing on global regulatory inspection management and GCP/GVP compliance. Tiffany holds a Master’s Degree in Quality Assurance and Regulatory Affairs from Temple University and a Bachelor's Degree in Public and Community Health from the University of Maryland.